| Literature DB >> 34198810 |
Niklas Meyer1,2, Johanne Egge Rinholm1,2.
Abstract
Myelin is a lipid-rich membrane that wraps around axons and facilitates rapid action potential propagation. In the brain, myelin is synthesized and maintained by oligodendrocytes. These cells have a high metabolic demand that requires mitochondrial ATP production during the process of myelination, but they rely less on mitochondrial respiration after myelination is complete. Mitochondria change in morphology and distribution during oligodendrocyte development. Furthermore, the morphology and dynamic properties of mitochondria in mature oligodendrocytes seem different from any other brain cell. Here, we first give a brief introduction to oligodendrocyte biology and function. We then review the current knowledge on oligodendrocyte metabolism and discuss how the available data on mitochondrial morphology and mobility as well as transcriptome and proteome studies can shed light on the metabolic properties of oligodendrocytes.Entities:
Keywords: ATP; glycolysis; metabolism; mitochondria; myelination; oligodendrocyte; oligodendrocyte precursor cell (OPC); oxidative phosphorylation; proteome; transcriptome
Year: 2021 PMID: 34198810 PMCID: PMC8226700 DOI: 10.3390/metabo11060359
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Metabolic fluxes between glia and axons and the proposed model of different functional states of mitochondria in oligodendrocytes during development. Myelinating oligodendrocytes metabolically support their isolated axonal segments in different ways via the direct transport of glucose and lactate and via the release of exosomes secreted from the myelin sheath. This support is only possible due to gap junction-coupled astrocytes that spread metabolites in the network. Oligodendrocytes sense axonal activity via NMDA receptors on the myelin sheath. This increases the intracellular Ca2+ concentration in the sheath, which causes lactate release. Since the small mitochondria in the myelin sheath move when Ca2+ is elevated, their movement away from the site of influx will facilitate release of lactate instead of lactate consumption. Proposed functions of myelin mitochondria include lipid metabolism and Ca2+ signaling. In contrast, mitochondria located in OPCs and immature oligodendrocytes show elongation and enrichment in the processes. These mitochondria have high oxidative phosphorylation (thereby consuming lactate) and are involved in Ca2+ signaling, cell differentiation, and initiation of myelination. See the main text for more details and references.
Density, length, and mobility of mitochondria in different cell types and compartments of the nervous system.
| Cell Type/Compartment. | Density | Length | Velocity µm/s | % Moving | References |
|---|---|---|---|---|---|
| Oligodendrocyte primary processes | 8.7 | 1.2 | 0.07 | 12 (20 min) | [ |
| Oligodendrocyte myelin sheaths | 2.4 | 0.8 | 0.08 | 8 (20 min) | [ |
| Astrocytes | - | 2.5–3 | 0.15–0.2 | 20 (15 min) | [ |
| Neuronal dendrites (CNS) | 141 | 2.5–3 | 0.3 | 40/50 (15/20 min) | [ |
| Neuronal axons (CNS) | 13–14 1 | 1.4 1 | 0.5–0.6 1 | - | [ |
| Schwann cell myelin sheaths | - | 1–3 2 | 0.14 2 | - | [ |
1 From primary cultures. 2 From in vivo measurements. All other values are from organotypic slice cultures. There is a lot of in vivo data published on mitochondrial movement in axons. These data were not included here due to differences in how movement was reported, but overall, in vivo data show somewhat lower mitochondrial mobility than in cell culture (for an overview, see [55]). We have not been able to find similar data for microglia. These cells are therefore not included in the table.
Figure 2RNA and protein expression of regulatory enzymes involved in glucose and pyruvate metabolism. Transcriptome and proteome data are from Zhang et al. [83] and Sharma et al. [84], respectively. Different cell types are indicated by different colors as explained in the top right panel. The study by Sharma et al. used isolated cells that were cultured and analyzed at different days in vitro (DIV), as indicated. (A) Expression of Pfkfb3, a major positive regulator of glycolysis. (B) Expression of the two lactate dehydrogenase isozymes LDHA and LDHB. (C) Expression of PDK3 and PDK4, which indirectly act as positive regulators of glycolysis by inhibiting pyruvate metabolism in mitochondria. See main text for details.